JP2018523483A5 - - Google Patents

Download PDF

Info

Publication number
JP2018523483A5
JP2018523483A5 JP2018509494A JP2018509494A JP2018523483A5 JP 2018523483 A5 JP2018523483 A5 JP 2018523483A5 JP 2018509494 A JP2018509494 A JP 2018509494A JP 2018509494 A JP2018509494 A JP 2018509494A JP 2018523483 A5 JP2018523483 A5 JP 2018523483A5
Authority
JP
Japan
Prior art keywords
polypeptide
medicament
fusion polypeptide
amino acid
medicament according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018509494A
Other languages
English (en)
Japanese (ja)
Other versions
JP6859320B2 (ja
JP2018523483A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/069680 external-priority patent/WO2017029389A1/en
Publication of JP2018523483A publication Critical patent/JP2018523483A/ja
Publication of JP2018523483A5 publication Critical patent/JP2018523483A5/ja
Application granted granted Critical
Publication of JP6859320B2 publication Critical patent/JP6859320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018509494A 2015-08-20 2016-08-19 臓器不全の治療および予防用のb7−h1融合ポリペプチド Active JP6859320B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15181800.2 2015-08-20
EP15181800 2015-08-20
PCT/EP2016/069680 WO2017029389A1 (en) 2015-08-20 2016-08-19 B7-h1 fusion polypeptides for treating and preventing organ failure

Publications (3)

Publication Number Publication Date
JP2018523483A JP2018523483A (ja) 2018-08-23
JP2018523483A5 true JP2018523483A5 (enExample) 2019-09-26
JP6859320B2 JP6859320B2 (ja) 2021-04-14

Family

ID=54014503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018509494A Active JP6859320B2 (ja) 2015-08-20 2016-08-19 臓器不全の治療および予防用のb7−h1融合ポリペプチド

Country Status (7)

Country Link
US (2) US10632174B2 (enExample)
EP (1) EP3337496B1 (enExample)
JP (1) JP6859320B2 (enExample)
CN (2) CN107921093B (enExample)
CA (1) CA2995987C (enExample)
ES (1) ES2851474T3 (enExample)
WO (1) WO2017029389A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202100467T1 (it) 2015-04-17 2021-09-14 Alpine Immune Sciences Inc Proteine immunomodulatorie con affinità regolabili
AU2017248830B2 (en) 2016-04-15 2023-03-09 Alpine Immune Sciences, Inc. CD80 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
EP3491013A1 (en) 2016-07-28 2019-06-05 Alpine Immune Sciences, Inc. Cd155 variant immunomodulatory proteins and uses thereof
JP2020511144A (ja) 2017-03-16 2020-04-16 アルパイン イミューン サイエンシズ インコーポレイテッド Pd−l2バリアント免疫調節タンパク質及びその使用
MX2019010887A (es) 2017-03-16 2019-10-15 Alpine Immune Sciences Inc Proteinas inmunomoduladoras de cb80 variante y usos de estas.
FI3596116T3 (fi) * 2017-03-16 2023-11-09 Alpine Immune Sciences Inc Immunomodulatorisia pd-l1-varianttiproteiineja ja niiden käyttöjä
SG11202006148UA (en) 2018-01-03 2020-07-29 Alpine Immune Sciences Inc Multi-domain immunomodulatory proteins and methods of use thereof
CN113727998A (zh) 2018-11-30 2021-11-30 高山免疫科学股份有限公司 Cd86变体免疫调节蛋白及其用途
US10650210B1 (en) 2019-03-18 2020-05-12 Haier Us Appliance Solutions, Inc. Method for authenticating a filter cartridge for a refrigerator appliance
KR20230003219A (ko) * 2020-04-30 2023-01-05 프라운호퍼 게젤샤프트 쭈르 푀르데룽 데어 안겐반텐 포르슝 에. 베. Pd-1에 대한 향상된 친화도를 가진 pd-l1 변이체
IL296209A (en) 2020-05-12 2022-11-01 Cue Biopharma Inc Multimeric t-cell modulatory polypeptides and methods of using them
JP2023541366A (ja) * 2020-09-09 2023-10-02 キュー バイオファーマ, インコーポレイテッド 1型真性糖尿病(t1d)を治療するためのmhcクラスii t細胞調節多量体ポリペプチド及びその使用方法
CN117642432A (zh) * 2021-05-17 2024-03-01 威斯康星校友研究基金会 用于诱导免疫耐受的合成蛋白
WO2026046055A1 (en) * 2024-08-26 2026-03-05 Ck Life Sciences Development Limited Pharmaceutical compositions and methods for preventing or treating cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2950814A4 (en) * 2013-01-31 2016-06-08 Univ Jefferson FUSION PROTEINS BASED ON PD-L1 AND PD-L2 AND USES THEREOF
EP3470081A1 (en) 2013-10-01 2019-04-17 Mayo Foundation for Medical Education and Research Methods for treating cancer in patients with elevated levels of bim

Similar Documents

Publication Publication Date Title
JP2018029594A5 (enExample)
Farrar et al. The innate immune system and transplantation
EP4282430A3 (en) Garp-tgf-beta antibodies
JP2017515460A5 (enExample)
Kroger et al. Therapies to suppress β cell autoimmunity in type 1 diabetes
JP2018512856A5 (enExample)
JP2020533273A5 (enExample)
JP2014530253A5 (enExample)
JP2016529229A5 (enExample)
JP2016527286A5 (enExample)
JP2014508748A5 (enExample)
JP2017538401A5 (enExample)
JP2020501550A5 (enExample)
JP2019519215A5 (enExample)
JP2013506411A5 (enExample)
HK1210792A1 (en) Molecules with antigen binding and polyvalent fc gamma receptor binding activity
JP2018509936A5 (enExample)
FI3421486T3 (fi) Uusia vista-ig-rakenteita ja vista-ig:n käyttö autoimmuuni-, allergia- ja tulehdushäiriöiden hoitamiseksi
JP2018509163A5 (enExample)
AU2014307725A1 (en) T cell receptors
JP2018520679A5 (enExample)
JP2018508219A5 (enExample)
JP2014110810A5 (enExample)
JP2018510132A5 (enExample)
JP2016527314A5 (enExample)